Spotlight Growth
No Result
View All Result
Friday, February 3, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Bio/Med/Pharma

These 3 Microcap Health Care Stocks Don’t Need a Checkup

by admin
July 20, 2018
in Bio/Med/Pharma, Opinion
0
These Three Microcap Health Care Stocks Don't Need a CheckUp Opinion

These Three Microcap Health Care Stocks Don't Need a CheckUp Opinion

An aging population, health care reform, proposed caps on drug prices, and small companies seeking blockbuster drugs. All of these characterize the health care sector, which can make investing in health care a full contact sport.

Let’s take a look at three microcaps that are performing well in the choppy health care market. While investing in these three stocks may not have quite the effect of Ambien, perhaps they will soothe your portfolio angst just a bit.

Source: Finviz.com
Source: Finviz.com

Investors in Avid Bioservices, Inc. (NASDAQ: CDMO) don’t have to worry about finding the next blockbuster drug. Avid decided to change gears last year from a drug company, to a dedicated CDMO (contract development and manufacturing organization).

Avid not only pivoted on it’s business model, but also on its name. Avid was known as Peregrine Pharmaceuticals until January of this year.

The business model change (Peregrine had done some CDMO work previously) threw a wrench into the company’s stock. But, as the new model has taken hold, the stock has recovered since February. It now looks to be relishing the new picks-and-shovels model. With earnings expected to grow over 75% next year, investors should consider the new model before Wall Street fully values the company as a CDMO.

Source: Finviz.com
Source: Finviz.com

Speaking of getting older, who doesn’t want a good chiropacter on call. The Joint Corporation (NASDAQ: JYNT) has brought a fresh face to the chiropractic practice.

The Joint has membership plans and a no appointment necessary policy at their over 400 clinics in 30 states. Offices have a non-clinical atmosphere, and they provide individualized plans for chiropractic health.

This new approach has put the stock on a solidly upward march in 2018, with earnings growth of over 103% this year. All-time highs of just over $12 may be within striking distance.

Source: Finviz.com
Source: Finviz.com

If you need more than chiropractic care, look no further than SeaSpine Holdings Corporation (NASDAQ: SPNE). SeaSpine provides a wide range of products to orthopedic surgeons to address spinal injuries and disorders.

Though still not profitable, the company has been slowly decreasing earnings losses the past few years. The stock has been stair-stepping higher this year, and has risen to new highs after every pullback.

Earnings are expected to grow over 22% next year, and if management continues the turnaround, the stock could be in for more moves to the upside.

These 3 health care stocks, Avid Bioservices, The Joint Corporation, and SeaSpine Holdings, offer investors solid business models and an opportunity for good returns in health care. Rest easy with management teams at these companies performing to plan.

Disclaimer: The author and Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party currently have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This content is meant for informational and entertainment purposes only and should not be meant as a recommendation to buy or sell any securities. Please visit a licensed financial representative to determine what investments are right for you.

Article By: Steven Adams

Tags: biopharmaceuticalsbiotechchiropractorcommon stockemerging growthhealthhealth carehealth care sectorinvestinginvestmentmedicalmedtechmicrocap stocksmicrocapsNASDAQNASDAQ stockspharmaceuticalspublic companysalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stockstradingtreatment
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023
Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023
ADVERTISEMENT

Recent News

Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested